StonvexLoading…
StonvexStonvexStonvexCore line items from SBSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $403.07M | $414.34M | $359.74M | $252.98M |
Operating Income | $82.63M | $107.38M | $101.13M | $119.63M |
Net Income | $69.22M | $88.49M | $86.69M | $105.02M |
EPS (Diluted) | $2.29 | $2.91 | $2.82 | $3.26 |
Total Assets | $8.51B | $8.52B | $8.28B | $7.56B |
Total Liabilities | $7.67B | $7.71B | $7.51B | $6.81B |
Cash & Equivalents | $389.79M | $426.16M | $560.51M | $199.25M |
Free Cash Flow OCF − CapEx | $73.48M | $90.69M | $72.96M | $217.22M |
Shares Outstanding | 30.23M | 30.37M | 30.76M | 32.25M |